Pigment epithelial detachment in exudative macular degeneration. Clinical characteristics and therapeutic options;Pigmentepithelabhebung bei exsudativer Makuladegeneration. Klinische Charakteristika und therapeutische Optionen

Ophthalmologe

Volumn 107, Issue 12, 2010, Pages 1115-1122

  Lommatzsch, A ^a  

^a ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

Age related macular degeneration; Anit VEGF therapy; Pigment epithelial detachment; Retinal angiomatous proliferation; Tears of retinal retinal pigment epithelium

Indexed keywords

VASCULOTROPIN A;

AGED; ARTICLE; BRUCH MEMBRANE; DRUG ANTAGONISM; EXUDATIVE MACULAR DEGENERATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; PIGMENT EPITHELIUM; PROGNOSIS; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA NEOVASCULARIZATION; RETINA TEAR; SUBRETINAL NEOVASCULARIZATION;

AGED; BRUCH MEMBRANE; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; LASER COAGULATION; PIGMENT EPITHELIUM OF EYE; PROGNOSIS; RETINAL DETACHMENT; RETINAL HEMORRHAGE; RETINAL NEOVASCULARIZATION; RETINAL PERFORATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WET MACULAR DEGENERATION;

EID: 78650243437     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-010-2143-6     Document Type: Article

References (73)

1. Aisenbrey S, Bartz-Schmidt K, Walter P et al (2007) Long-term follow-up of macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 125: 1367-1372.
2. Anonymous (2005) New drug treats form of age-related macular degeneration. Macugen inhibits progression of wet AMD and also may restore some vision. Health News 11: 3-4.
3. Anonymous (2000) Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology. Ophthalmology 107: 2314-2317.
4. Anonymous (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131: 541-560.
5. Augustin A, Schmidt-Erfurth U (2006) Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology 113: 14-22.
6. Axer-Siegel R, Ehrlich R, Rosenblatt I et al (2004) Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol 122: 453-459.
7. Barondes M, Pagliarini S, Chisholm I et al (1992) Controlled trial of laser photocoagulation of pigment epithelial detachments in the elderly: 4 year review. Br J Ophthalmol 76: 5-7.
8. Baumal C, Reichel E, Duker J et al (1997) Indocyanine green hyperfluorescence associated with serous retinal pigment epithelial detachment in age-related macular degeneration. Ophthalmology 104: 761-769.
9. Bird A, Bressler N, Bressler S et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The international ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374.
10. Bird A, Marshall J (1986) Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc U K 105 (Pt 6): 674-682.
11. Boscia F, Furino C, Sborgia L et al (2004) Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138: 1077-1079.
12. Brancato R, Introini U, Bolognesi G et al (2000) ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography. Retina 20: 134-142.
13. Bressler N, Bressler S (1995) Preventative ophthalmology. Age-related macular degeneration. Ophthalmology 102: 1206-1211.
14. Bressler N, Finklestein D, Sunness J et al (1990) Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. Arch Ophthalmol 108: 1694-1697.
15. Bressler S (1989) Health maintenance issues of the elderly. Vision: age-related macular degeneration. Md Med J 38: 135-137.
16. Brown D, Kaiser P, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: 1432-1444.
17. Brumm G, Spital G, Radermacher M et al (2002) Pigment epithelial detachments in age-related macular degeneration - classification, differentiation and prognosis. Klin Monatsbl Augenheilkd 219: 791-796.
18. Casswell A, Kohen D, Bird A (1985) Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69: 397-403.
19. Colucciello M, Ginsburg L, Sammartino J (1997) Indocyanine green angiographic evaluation of retinal pigment epithelial tears. Retina 17: 23-27.
20. Coscas F, Stanescu D, Coscas G et al (2003) Feeder vessel treatment of choroidal neovascularization in age-related macular degeneration. J Fr Ophtalmol 26: 602-608.
21. Dasch B, Fuhs A, Meister A et al (2005) Association between classic cardiovascular risk factors and age-related maculopathy (ARM). Results of the baseline examination of the Munster Aging and Retina Study (MARS). Ophthalmologe 102: 1057-1063.
22. Fang I, Lin Yc, Yang Ch et al (2009) Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration. Eye (Lond) 23: 397-406.
23. Garg S, Brod R, Kim D et al (2008) Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration. Clin Experiment Ophthalmol 36: 252-256.
24. Gelisken F, Inhoffen W, Partsch M et al (2001) Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 131: 518-520.
25. Gelisken F, Ziemssen F, Voelker M et al (2009) Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye (Lond) 23: 694-702.
26. Gerding H (2010) Treatment of wet AMD with less than 12 injections of Ranibizumab per year. Klin Monbl Augenheilkd 227: 294-297.
27. Giovannini A, Amato G, Mariotti C et al (2000) Optical coherence tomography in the assessment of retinal pigment epithelial tear. Retina 20: 37-40.
28. Green W, Enger C (1993) Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 100: 1519-1535.
29. Haines J, Hauser M, Schmidt S et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
30. Hara R, Kawaji T, Inomata Y et al (2010) Photodynamic therapy alone versus combined with intravitreal bevacizumab for neovascular age-related macular degeneration without polypoidal choroidal vasculopathy in Japanese patients. Graefes Arch Clin Exp Ophthalmol.
31. Hawkins B, Bird A, Klein R et al (1999) Epidemiology of age-related macular degeneration. Mol Vis 5: 26.
32. Heier J, Antoszyk A, Pavan P et al (2006) Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology 113: 633 e631-e634.
33. Holz F, Bellmann C, Margaritidis M et al (1999) Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 237: 145-152.
34. Holz F, Pauleikhoff D, Klein R et al (2004) Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 137: 504-510.
35. Hughes A, Orr N, Esfandiary H et al (2006) A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38: 1173-1177.
36. Kaiser P (2010) Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand? Br J Ophthalmol 94: 143-145.
37. Khan J, Thurlby D, Shahid H et al (2006) Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90: 75-80.
38. Koenig F, Soubrane G, Coscas G (1989) Retinal pigment epithelial tears after photocoagulation in age-related macular degeneration. J Fr Ophtalmol 12: 775-780.
39. Konstantinidis L, Ambresin A, Zografos L et al (2009) Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration. Acta Ophthalmol.
40. Kook D, Wolf A, Neubauer A et al (2008) Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress. Ophthalmologe 105: 158-164.
41. Kopitz J, Holz F, Kaemmerer E et al (2004) Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie 86: 825-831.
42. Krebs I, Binder S, Stolba U (2006) A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244: 863-867.
43. Krishan N, Chandra S, Stevens T (1985) Diagnosis and pathogenesis of retinal pigment epithelial tears. Am J Ophthalmol 100: 698-707.
44. Lafaut B, Aisenbrey S, Vanden Broecke C et al (2001) Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol 85: 454-460.
45. Lommatzsch A, Heimes B, Gutfleisch M et al (2010) Retinal angiomatous proliferation with associated pigment epithelium detachment: Anti-VEGF therapy. Ophthalmologe.
46. Lommatzsch A, Heimes B, Gutfleisch M et al (2009) Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye.
47. Lommatzsch A, Heimes B, Gutfleisch M et al (2009) Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye (Lond) 23: 2163-2168.
48. Lommatzsch A, Hermans P, Muller KD et al (2008) Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch Clin Exp Ophthalmol 246: 803-810.
49. Lommatzsch A, Hermans P, Weber B et al (2007) Complement factor H variant Y402H and basal laminar deposits in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245: 1713-1716.
50. Lommatzsch A, Heimes B, Gutfleisch M et al (2008) Treatment of vascularised serous pigment epithelium detachment in AMD - observations after changing the intravitreal agent due to lack of response. Klin Monatsbl Augenheilkd 225: 874-879.
51. Machemer R (1998) Macular translocation. Am J Ophthalmol 125: 698-700.
52. Monson D, Smith J, Klein M et al (2008) Clinicopathologic correlation of retinal angiomatous proliferation. Arch Ophthalmol 126: 1664-1668.
53. Pauleikhoff D, Holz F (1996) Age-related macular degeneration. 1. Epidemiology, pathogenesis and differential diagnosis. Ophthalmologe 93: 299-315.
54. Pauleikhoff D, Loffert D, Spital G et al (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240: 533-538.
55. Pece A, Introini U, Bottoni F et al (2001) Acute retinal pigment epithelial tear after photodynamic therapy. Retina 21: 661-665.
56. Ronan S, Yoganathan P, Chien F et al (2007) Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Retina 27: 535-540.
57. Rosenfeld P, Brown D, Heier J et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419-1431.
58. Rosenfeld P, Moshfeghi A, Puliafito C (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36: 331-335.
59. Rudnisky C, Liu C, Ng M et al (2010) Intravitreal bevacizumab alone versus combined verteporfin photodynamic therapy and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration: visual acuity after 1 year of follow-up. Retina 30: 548-554.
60. Sacu S, Stifter E, Vecsei-Marlovits P et al (2009) Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration. Eye (Lond) 23: 1404-1410.
61. Scholl H, Weber B, Nothen M et al (2005) Y402H polymorphism in complement factor H and age-related macula degeneration (AMD). Ophthalmologe 102: 1029-1035.
62. Smith B, Kraus C, Apte R (2009) Retinal pigment epithelial tears in ranibizumab-treated eyes. Retina 29: 335-339.
63. Spaide R (2009) Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 147: 644-652.
64. Spital G, Brumm G, Radermacher M et al (2000) Volume determination of pigment epithelium detachment in AMD by laser scanning tomography. Ophthalmologe 97: 173-180.
65. Treumer F, Klatt C, Roider J et al (2010) Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage. Br J Ophthalmol 94: 48-53.
66. van Meurs J, Ter Averst E, Hofland L et al (2004) Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol 88: 110-113.
67. van Meurs JC, van Den Biesen PR (2003) Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol 136: 688-695.
68. Viola F, Massacesi A, Orzalesi N et al (2009) Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 29: 732-739.
69. Yannuzzi L, Freund K, Takahashi B (2008) Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 28: 375-384.
70. Yannuzzi L, Hope-Ross M, Slakter J et al (1994) Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 14: 99-113.
71. Yannuzzi L, Negrao S, Iida T et al (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21: 416-434.
72. Yates J, Sepp T, Matharu B et al (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561.
73. Yuzawa M, Kawamura A, Yamaguchi C et al (1995) Indocyanine green videoangiographic findings in detachment of the retinal pigment epithelium. Ophthalmology 102: 622-629.